Immunos Therapeutics raised €68M in a Series B round in Jun 2022. The company is based in Schlieren, Switzerland. Investors in the round: BioMed Partners, Fiscus Financial, Gimv and 7 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
